title: [Fibromyalgia diagnosis, treatment and prognosis].
abstract: It is important to recognize the diagnosis of fibromyalgia (FM) to adequately advise patients with this chronic pain disease. FM coexists with other rheumatic diseases and may therefore serve as a confounder in connection with estimation of disease activity. The aetiology and pathogenesis of FM remain unknown, although central sensitisation seems to play a major role. Following exclusion of a number of differential diagnoses, the remaining patients have several treatment options including centrally-acting medication.
authors.affiliation: Parker Instituttet - Den Reumatologiske Forskningsenhed, Frederiksberg Hospital, 2000 Frederiksberg, Denmark. bds@frh.regionh.dk
authors.forename: Bente
authors.initials: B
authors.lastname: Danneskiold-Samsøe
authors.forename: Else Marie
authors.initials: EM
authors.lastname: Bartels
authors.forename: Kirstine
authors.initials: K
authors.lastname: Amris
authors.forename: Henning
authors.initials: H
authors.lastname: Bliddal
mesh_terms: D000700:Analgesics / Q000008:administration & dosage; D000928:Antidepressive Agents / Q000008:administration & dosage; D002908:Chronic Disease; D015928:Cognitive Behavioral Therapy; D003937:Diagnosis, Differential; D005081:Exercise Therapy; D005356:Fibromyalgia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D009209:Myofascial Pain Syndromes / Q000175:diagnosis; D011379:Prognosis
chemical_list: D000700:Analgesics; D000928:Antidepressive Agents